8/2000-5/2003 School of Pharmacy and Pharmaceutical Sciences
Purdue University, West Lafayette, IN
Doctor of Pharmacy
9/1996-6/1998 Graduate Institutes of Pharmaceutical Sciences
National Taiwan University, Taipei, Taiwan
Master of Science
10/1992-6/1996 School of Pharmacy
National Taiwan University, Taipei, Taiwan
Bachelor of Science
經歷
:
2007.10-present:Clinical Pharmacist, Department of Pharmacy, National Taiwan University Hospital
9/2005-7/2007 Clinical Pharmacist, Infectious Diseases / Clinical Instructor
Department of Pharmacy Services
Hahnemann University Hospital, Philadelphia, PA
University of Sciences in Philadelphia, Philadelphia College of Pharmacy
7/2004-6/2005 Pharmacy Specialty Resident in Infectious Diseases / Clinical Instructor
Department of Pharmacy Services and College of Pharmacy
University of Michigan Health System, Ann Arbor, MI
7/2003-6/2004 ASHP Accredited Pharmacy Practice Resident / Clinical Instructor
Department of Pharmacy Services and College of Pharmacy,
University of Michigan Health System, Ann Arbor, MI
9/2001-8/2002 Undergraduate Research Assistant
Department of Pharmacy Practice, Purdue University, West Lafayette, IN
6/2001-8/2001 Summer Undergraduate Research Fellow
Department of Pharmacy Practice, Purdue University, Indianapolis, IN
2/2000-7/2000 Teaching Assistant
School of Pharmacy, National Taiwan University, Taipei, Taiwan
8/1999-1/2000 Clinical Research Associate
Abbott Laboratories Service Corp., Taiwan Branch, Taipei, Taiwan
7/1998-7/1999 Research Assistant
College of Public Health, National Taiwan University, Taipei, Taiwan
榮譽
:
May 2003 Doctor of Pharmacy with Distinction
Spring 2002 Robert C. Anderson Family scholarship
Fall 2001- Rho Chi Society membership
Spring 2001 Helen K. Carney’s scholarship
Fall 2000-Spring 2002 Dean’s List and Semester Honors
Fall 1996 Research Creativity Award from the National Science Council, Taiwan
Development and Clinical Application of a Real-World Population Pharmacokinetic Model of Rivaroxaban in Asian Patients with Atrial Fibrillation (2026-06) Lai, Nian-Shiuan ; CHUN-JUNG LIN ; CHING-HUA KUO ; Peng, Yu-Fong ; CHIH-FEN HUANG ; SUNG-CHUN TANG ; SHIN-YI LIN ; SHU-WEN LIN
Divergent Small Vessel Disease Burden in Warfarin-Associated and Direct Oral Anticoagulant-Associated Intracerebral Hemorrhage (2026-05) SUNG-CHUN TANG ; Chao, Yuan-Chang ; Chen, Ya-Fang ; CHING-HUA KUO ; CHIH-HAO CHEN ; Peng, Yu-Fong ; SHU-WEN LIN ; SHIN-YI LIN ; JIANN-SHING JENG
Ventricular Arrhythmia and Sudden Death Risk With Concomitant Antipsychotic and SSRI Use (2026-04-09) Chien, Hsiu-Ting ; SHU-WEN LIN ; Kung, Te-Jung ; Dong, Yaa-Hui ; CHI-CHUAN WANG ; Toh, Sengwee ; TZUNG-JENG HWANG ; FANG-JU LIN
Voriconazole as a Secondary Prophylaxis for Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplantation: Real-world Evidence From a Major Transplantation Center in Taiwan. (2026-03) Wang, Yu-Wen ; Cheng, Chih-Ning ; Lin, Chien-Ting ; Xavier Cheng-Hong Tsai ; Huang, Jiun-Da ; Hsieh, Zong-Da ; Liao, Xiu-Wen ; FANG-JU LIN ; YEE-CHUN CHEN ; CHING-HUA KUO ; SHU-WEN LIN ; SHANG-JU WU
The Impact of QT-Prolonging Medications and Drug–Drug Interactions on QTc Interval Prolongation in Hospitalized Patients: A Case-Crossover Study (2025-02) Chien, Hsiu-Ting ; FANG-JU LIN ; JYH-MING JIMMY JUANG ; SHU-WEN LIN
Clinical Efficacy and Pharmacokinetics of Cefiderocol for Carbapenem-Resistant Enterobacterales Infections: with Special Emphasis on Treatment Strategy of Ndm-Producing Enterobacterales = Cefiderocol用於治療碳青黴烯抗藥性腸桿菌感染之臨床療效與藥物動力學分析: 特別著重產NDM碳青黴烯酶腸桿菌之治療策略 (2025-08-01~) YU-SHAN HUANG
HIV/AIDS Control and Study Center (VI) = 愛滋病防治整合型中程計畫─愛滋病防治中心 (VI) (2026-01-01~) CHIEN-CHING HUNG
Optimization of Anti-Mycobacterial Therapy among Patients with Anti-Interferon-Gamma Autoantibodies through Therapeutic Drug Monitoring (Extended Study) (II) = 抗丙型干擾素自體抗體病人使用抗分枝桿菌藥物之療效監測與精準劑量探討 (延伸研究) (II) (2024-08-01~) UN-IN WU
利用臨床案例平台與即時反饋系統改善臨床藥動學之學習成效
=Using a case platform and interactive response system to improve the learning in clinical pharmacokinetics (2023-08-01~) Lin, Shu-Wen
Optimization of Anti-Mycobacterial Therapy among Patients with Ani-Interferon-Gamma Autoantibodies through Therapeutic Drug Monitoring (I) = 抗丙型干擾素自體抗體病人使用抗分枝桿菌藥物之療效監測與精準劑量探討 (I) (2023-08-01~) UN-IN WU